Skip to main content
. 2021 Jun 9;11(6):534. doi: 10.3390/jpm11060534

Table 4.

The adverse effects of the study population †.

Parameter Concomitant Therapy 1
(N = 40)
Tailored Therapy 1
(N = 40)
p *
Nausea 7 (17.5) 3 (7.5) 0.311
Stomach pain 1 (2.5) 0 (0.0) 0.998
Skin rash 2 (5.0) 0 (0.0) 0.493
Metallic taste 2 (5.0) 0 (0.0) 0.493
Headache 1 (2.5) 0 (0.0) 0.998
Diarrhea 1 (2.5) 0 (0.0) 0.998
Tongue deposits 1 (2.5) 0 (0.0) 0.998

1 Data are presented as a whole number and percentages. * Fisher’s exact test. † Some patients had more than one adverse effect.